Najima, Yuho
Maeda, Tomoya
Kamiyama, Yutaro
Nakao, Shinji
Ozaki, Yukinori
Nishio, Hiroshi
Tsuchihashi, Kenji
Ichihara, Eiki
Miumra, Yuji
Endo, Makoto
Maruyama, Dai
Yoshinami, Tetsuhiro
Susumu, Nobuyuki
Takekuma, Munetaka
Motohashi, Takashi
Ito, Mamoru
Baba, Eishi
Ochi, Nobuaki
Kubo, Toshio
Uchino, Keita
Kimura, Takahiro
Tamura, Shinobu
Nishimoto, Hitomi
Kato, Yasuhisa
Sato, Atsushi
Takano, Toshimi
Yano, Shingo
Article History
Received: 13 September 2023
Accepted: 14 December 2023
First Online: 17 May 2024
Declarations
:
: T. Maeda reports scholarship donation from Chugai Pharmaceutical. SN reports honoraria from Kyowa Kirin. YO reports honoraria from Daiichi Sankyo, Pfizer, Chugai Pharmaceutical, Eli Lilly and Company, and Kyowa Kirin. KT reports honoraria from Ono Pharmaceutical, Chugai Pharmaceutical, Taiho Pharmaceutical, and Novartis Pharma. EI reports honoraria from Eli Lilly and Company, research funding from MSD, Ono Pharmaceutical, Jannsen Pharma, and Takeda Pharmaceutical. YM reports honoraria from Ono Pharmaceutical, MSD, Takeda Pharmaceutical, Eisai, Bristol Myers Squibb, research funding from MSD, and Ono Pharmaceutical. DM reports honoraria from Ono Pharmaceutical, Janssen Pharma, Nippon Shinyaku, Eisai, Mundipharma, Kyowa Kirin, Chugai Pharmaceutical, Zenyaku, MSD, SymBio Pharmaceuticals, Sanofi, AbbVie, Takeda Pharmaceutical, AstraZeneca, Bristol Myers Squibb, Genmab, research funding from Amgen Astellas Biopharma, Novartis Pharma, Kyowa Kirin, Ono Pharmaceutical, Chugai Pharmaceutical, Janssen Pharma, Takeda Pharmaceutical, Otsuka Pharmaceutical, Sanofi, Astellas, Bristol Myers Squibb, AbbVie, Eisai, MSD, Taiho Pharmaceutical, AstraZeneca, Eli Lilly and Company, and Genmab. TY reports honoraria from Kyowa Kirin, Pfizer, Chugai Pharmaceutical, Eli Lilly and Company, MSD, AstraZeneca, and Eisai. T. Motohashi reports honoraria from AstraZeneca, Chugai Pharmaceutical, and Myriad Genetics. EB reports honoraria from Chugai Pharmaceutical, Daiichi Sankyo, research funding from Taiho Pharmaceutical, and Chugai Pharmaceutical. T. Kubo reports honoraria from Chugai Pharmaceutical. T. Kimura reports honoraria from Sanofi. AS reports honoraria and research funding from Chugai Pharmaceutical, and Taiho Pharmaceutical. TT reports honoraria from Daiichi Sankyo, Chugai Pharmaceutical, and Eli Lilly and Company. SY reports research funding from Otsuka Pharmaceutical. The other authors declare that there are no conflicts of interest associated with this manuscript.
: Not applicable.
: Formal consent was not required for this type of study.
: Not applicable.
: All authors consented to the publication of this study.